DESMOID
Clinical trials for DESMOID explained in plain language.
Never miss a new study
Get alerted when new DESMOID trials appear
Sign up with your email to follow new studies for DESMOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare tumor patients: chemo delivered directly to tumors
Disease control Recruiting nowThis study is for people with symptomatic desmoid tumors that are growing and cannot be treated with surgery or cryoablation. The treatment involves delivering a chemotherapy drug (doxorubicin) directly into the tumor's blood vessels to shrink it and reduce pain. Researchers will…
Matched conditions: DESMOID
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated May 17, 2026 01:50 UTC
-
New drug FOG-001 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug, FOG-001, in about 595 people with advanced solid tumors that have not responded to other treatments. The goal is to see if FOG-001 is safe and can shrink tumors or slow their growth. The trial focuses on several cancer types, including colorectal, pro…
Matched conditions: DESMOID
Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New imaging method may spot tumor progression earlier than standard scans
Knowledge-focused Recruiting nowThis study looks at whether a special MRI analysis called radiomics can predict if a desmoid tumor will grow back after cryoablation (freezing treatment). Desmoid tumors are non-cancerous but can be painful and aggressive. The study will compare radiomics to standard size-based c…
Matched conditions: DESMOID
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated May 17, 2026 01:48 UTC